Note: Ingredients listed on restricted chemical lists
EC/CAS
200-659-6/67-56-1
Name of the chemical
Methanol
Concentration
>=30-<50 >=20-<30 603-001-
General Information
Version
8.1
Revision date
2023-06-18
Product name
Ultrogel AcA 54
1.2.1 Relevant identified uses
Laboratory chemicals, Synthesis of substances
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H312+H332, H370
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Signal word
Danger
Hazard statements
H302 + H312 + H332 Harmful if swallowed, in contact with skin or if inhaled. H370 Causes damage to organs.
Precautionary statements
P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/ protective clothing. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P307 + P311 IF exposed: Call a POISON CENTER or doctor/ physician. P322 Specific measures (see supplemental first aid instructions on this label). P330 Rinse mouth. P363 Wash contaminated clothing before reuse. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
- none
2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) Acute toxicity, Oral (Category 4), H302 Acute toxicity, Inhalation (Category 4), H332 Acute toxicity, Dermal (Category 4), H312 Specific target organ toxicity - single exposure (Category 1), H370 For the full text of the H-Statements mentioned in this Section, see Section 16.
